Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

AMT® shows promise as a safe and effective treatment for early-stage knee osteoarthritis.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

A woman got a skin rash from taking aceclofenac, which went away after she stopped the drug.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Tofacitinib is a promising treatment for children with rheumatic diseases.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

miRNAs could help diagnose and treat gouty arthritis.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

ASC-CM is more effective than EV for treating osteoarthritis.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

PRP may help short-term with ankle arthritis pain, but long-term effects are unclear.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Leflunomide is more likely to help treat alopecia areata than cause it.

A combined Dermatology and Rheumatology Clinic showed that skin issues often weren't linked to rheumatic diseases, highlighting the benefits of a team approach.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

Alopecia areata patients often have other autoimmune diseases, especially women with nail issues or atopic diseases.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

A patient's grey hair regained color during treatment with adalimumab.